Immunological risk factors in heart transplantation

David Ansari

Immunological risk factors in heart transplantation

David Ansari

Research output: Thesis › Doctoral Thesis (compilation)

507 Downloads (Pure)

Original language	English
Qualification	Doctor
Awarding Institution	Department of Clinical Sciences, Lund
Supervisors/Advisors	Nilsson, Johan, Supervisor Ohlsson, Mattias, Supervisor
Award date	2016 Sept 9
Place of Publication	Lund
Publisher	Lund University: Faculty of Medicine
ISBN (Print)	978-91-7619-303-7
Publication status	Published - 2016

Bibliographical note

Defence details
Date: 2016-09-09
Time: 13:00
Place: Segerfalksalen, BMC, A10, Sölvegatan 17, Lund.
External reviewer(s)
Name: Dellgren, Göran
Title: associate professor
Affiliation: Sahlgrenska University Hospital, Gothenburg
---
ISSN: 1652-8220
Lund University, Faculty of Medicine Doctoral Dissertation Series 2016:77

Subject classification (UKÄ)

Medical and Health Sciences

Access to Document

E-spik%20David%20A-2Final published version, 6.19 MB

3 Article

Comparison of Basiliximab and Anti-Thymocyte Globulin as Induction Therapy in Pediatric Heart Transplantation: A Survival Analysis.
Ansari, D., Höglund, P., Andersson, B. & Nilsson, J., 2015, In: Journal of the American Heart Association. 5, 1, e002790.
Research output: Contribution to journal › Article › peer-review

Open Access
Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab.
Ansari, D., Lund, L. H., Stehlik, J., Andersson, B., Höglund, P., Edwards, L. & Nilsson, J., 2015, In: The Journal of Heart and Lung Transplantation. 34, 10, p. 1283-1291
Research output: Contribution to journal › Article › peer-review
Human Leukocyte Antigen Matching in Heart Transplantation: Systematic Review and Meta-analysis.
Ansari, D., Bućin, D. & Nilsson, J., 2014, In: Transplant International. 27, 8, p. 793-804
Research output: Contribution to journal › Article › peer-review

Cite this

@phdthesis{986fbb79c2f248838a30826edc7dd96a,

title = "Immunological risk factors in heart transplantation",

keywords = "Heart Transplantation, induction, basiliximab, antithymocyte globulin, HLA, Human Leukocyte Antigen (HLA)",

author = "David Ansari",

note = "Defence details Date: 2016-09-09 Time: 13:00 Place: Segerfalksalen, BMC, A10, S{\"o}lvegatan 17, Lund. External reviewer(s) Name: Dellgren, G{\"o}ran Title: associate professor Affiliation: Sahlgrenska University Hospital, Gothenburg --- ISSN: 1652-8220 Lund University, Faculty of Medicine Doctoral Dissertation Series 2016:77",

year = "2016",

language = "English",

isbn = "978-91-7619-303-7",

publisher = "Lund University: Faculty of Medicine",

type = "Doctoral Thesis (compilation)",

school = "Department of Clinical Sciences, Lund",

}

TY - THES

T1 - Immunological risk factors in heart transplantation

AU - Ansari, David

N1 - Defence details Date: 2016-09-09 Time: 13:00 Place: Segerfalksalen, BMC, A10, Sölvegatan 17, Lund. External reviewer(s) Name: Dellgren, Göran Title: associate professor Affiliation: Sahlgrenska University Hospital, Gothenburg --- ISSN: 1652-8220 Lund University, Faculty of Medicine Doctoral Dissertation Series 2016:77

PY - 2016

Y1 - 2016

KW - Heart Transplantation

KW - induction

KW - basiliximab

KW - antithymocyte globulin

KW - HLA

KW - Human Leukocyte Antigen (HLA)

M3 - Doctoral Thesis (compilation)

SN - 978-91-7619-303-7

PB - Lund University: Faculty of Medicine

CY - Lund

ER -

Immunological risk factors in heart transplantation

Bibliographical note

Subject classification (UKÄ)

Access to Document

Research output

Comparison of Basiliximab and Anti-Thymocyte Globulin as Induction Therapy in Pediatric Heart Transplantation: A Survival Analysis.

Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab.

Human Leukocyte Antigen Matching in Heart Transplantation: Systematic Review and Meta-analysis.

Cite this